Literature DB >> 15240508

Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism.

Midori Yoshida1, Sayumi Katashima, Jin Ando, Takuji Tanaka, Fumiyuki Uematsu, Dai Nakae, Akihiko Maekawa.   

Abstract

Indole-3-carbinol (I3C), found in cruciferous vegetables, has been shown to suppress or promote carcinogenesis depending on various animal models. Regarding its preventive effects, I3C acts as an anti-estrogen and can induce apoptosis, but precise mechanisms remain to be determined. Since I3C induces cytochrome P450 enzymes in the liver, it affects hydroxylation of estrogens and might therefore be expected to influence endometrial adenocarcinoma development. The present study was performed to clarify the effects of I3C using a rat two-stage endometrial carcinogenesis model, focusing on induction of cytochrome P450s and other estrogen-metabolic enzymes in the liver. First, to determine the estrogenic or anti-estrogenic activity, an uterotropic assay was conducted using ovariectomized Donryu rats (experiment 1). Second, to elucidate the effects on endometrial carcinogenicity, female Donryu rats initiated with a single dose of N-ethyl-N'-nitro-N-nitrosoguanidine into a uterine horn were fed 0 or 500 p.p.m. I3C in diets for 12 months (experiment 2). In experiment 3, similarly initiated animals received 0 or 2000 p.p.m. I3C in their diet, or 1 microg/kg 17beta-estradiol (E2) or 5 microg/kg 4-hydroxyestradiol (4HE) subcutaneously twice a week for 12 months. In the uterotrophic assay, neither 500 nor 2000 p.p.m. of I3C showed any estrogenic or anti-estrogenic activity. In the two uterine carcinogenicity studies, I3C and 4HE increased incidences of uterine adenocarcinomas and/or multiplicities of uterine proliferative lesions, E2-treatment being associated with a tendency for promotion. In the liver, I3C treatment consistently elevated estradiol 2- and 4-hydroxylase activities, in particular the latter, but without effects on estradiol 16alpha-hydoxylase activity. mRNAs for CYP 1A1, 1A2 and 1B1 were increased by I3C treatment, with translation confirmed immunohistochemically. These results suggest that induction of the CYP 1 family in the liver and sequential modulation of estrogen metabolism to increase 4HE might play a crucial role in promoting the effects of dietary I3C on endometrial adenocarcinoma development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240508     DOI: 10.1093/carcin/bgh225

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

1.  3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Kyung-Won Min; Xiaobo Zhang; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2012-07-21       Impact factor: 6.048

2.  Intake of fruits and vegetables, and risk of endometrial cancer in the NIH-AARP Diet and Health Study.

Authors:  Geoffrey C Kabat; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; Thomas E Rohan
Journal:  Cancer Epidemiol       Date:  2010-07-08       Impact factor: 2.984

Review 3.  Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis.

Authors:  Jane V Higdon; Barbara Delage; David E Williams; Roderick H Dashwood
Journal:  Pharmacol Res       Date:  2007-01-25       Impact factor: 7.658

4.  Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma.

Authors:  Hany A Omar; Aaron M Sargeant; Jing-Ru Weng; Dasheng Wang; Samuel K Kulp; Tushar Patel; Ching-Shih Chen
Journal:  Mol Pharmacol       Date:  2009-08-25       Impact factor: 4.436

5.  OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signaling.

Authors:  Jing-Ru Weng; Chen-Hsun Tsai; Hany A Omar; Aaron M Sargeant; Dasheng Wang; Samuel K Kulp; Charles L Shapiro; Ching-Shih Chen
Journal:  Carcinogenesis       Date:  2009-08-25       Impact factor: 4.944

6.  Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects.

Authors:  Gregory A Reed; Jean M Sunega; Debra K Sullivan; John C Gray; Matthew S Mayo; James A Crowell; Aryeh Hurwitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

Review 7.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).

Authors:  Sompon Wanwimolruk; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-04-02       Impact factor: 4.068

Review 8.  Attenuation of Carcinogenesis and the Mechanism Underlying by the Influence of Indole-3-carbinol and Its Metabolite 3,3'-Diindolylmethane: A Therapeutic Marvel.

Authors:  V L Maruthanila; J Poornima; S Mirunalini
Journal:  Adv Pharmacol Sci       Date:  2014-05-08

9.  Involvements of Estrogen Receptor, Proliferating Cell Nuclear Antigen and p53 in Endometrial Adenocarcinoma Development in Donryu Rats.

Authors:  Midori Yoshida; Shin-Ichi Katsuda; Akihiko Maekawa
Journal:  J Toxicol Pathol       Date:  2012-12-20       Impact factor: 1.628

10.  Mechanisms and therapeutic implications of cell death induction by indole compounds.

Authors:  Aamir Ahmad; Wael A Sakr; Km Wahidur Rahman
Journal:  Cancers (Basel)       Date:  2011-07-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.